Probiotics for diarrhea in adults
Pro Research Analysisby 
Searched over 200M research papers
Probiotics for Diarrhea in Adults: A Comprehensive Review
Introduction to Probiotics and Diarrhea
Probiotics, which are live microorganisms that confer health benefits to the host when administered in adequate amounts, have been extensively studied for their potential to prevent and treat various forms of diarrhea in adults. This article synthesizes findings from multiple research studies to provide a clear understanding of the efficacy of probiotics in managing diarrhea, particularly antibiotic-associated diarrhea (AAD) and Clostridium difficile-associated diarrhea (CDAD).
Probiotics for Antibiotic-Associated Diarrhea (AAD)
Efficacy in Preventing AAD
Several studies have demonstrated that probiotics can significantly reduce the incidence of AAD in adults. A meta-analysis of 42 studies involving 11,305 participants found that co-administration of probiotics with antibiotics reduced the risk of AAD by 37% 2. Another meta-analysis of 36 studies with 9,312 participants reported a 38% reduction in AAD incidence with probiotic use 3. These findings are consistent across different probiotic species and dosages, with higher doses showing increased effectiveness 23.
Specific Probiotic Strains
The effectiveness of probiotics in preventing AAD varies by strain. Lactobacillus and Bifidobacterium genera have been particularly effective 2. A study focusing on Lactobacillus probiotics found a significant reduction in AAD risk, although the evidence was less conclusive for elderly patients 7.
Probiotics for Clostridium difficile-Associated Diarrhea (CDAD)
Prevention of CDAD
Probiotics have also been shown to be effective in preventing CDAD, a severe form of diarrhea often associated with antibiotic use. A systematic review and meta-analysis of 31 randomized controlled trials involving 8,672 patients found that probiotics reduced the risk of CDAD by 60% 1. Another meta-analysis of 26 RCTs with 7,957 patients reported a similar 60.5% reduction in CDAD incidence 10. These studies highlight the potential of probiotics, particularly Lactobacillus and Saccharomyces strains, in reducing CDAD risk 110.
Safety and Adverse Events
The use of probiotics in preventing CDAD appears to be safe, with a lower incidence of adverse events compared to control groups. Common adverse events included abdominal cramping, nausea, and flatulence, but these were generally mild and less frequent in the probiotic groups 1.
Probiotics for Acute Infectious Diarrhea
Treatment Efficacy
Probiotics may also be beneficial in treating acute infectious diarrhea. A review of 82 studies involving 12,127 participants found that probiotics reduced the duration of diarrhea by an average of 30.48 hours 6. However, the evidence was less clear for the prevention of diarrhea lasting 48 hours or longer, with some studies showing no significant difference between probiotic and control groups 4.
Strain-Specific Effects
The effectiveness of probiotics in treating acute infectious diarrhea also varies by strain. Lactobacillus rhamnosus GG and Saccharomyces boulardii have shown promise in reducing the duration and severity of diarrhea 46.
Conclusion
Probiotics have demonstrated significant potential in preventing and treating various forms of diarrhea in adults, particularly antibiotic-associated and Clostridium difficile-associated diarrhea. The evidence supports the use of specific probiotic strains, such as Lactobacillus and Bifidobacterium, for these conditions. While probiotics are generally safe, further research is needed to determine the optimal strains and dosages for different types of diarrhea.
Sources and full results
Most relevant research papers on this topic